Nan Zhou

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Cell Proliferation

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Nan Zhou, Luca Busino
Targeting epigenetics and ferroptosis in DLBCL. Blood 142 (13) (2023)
Nan Zhou, Jaewoo Choi, Grant Peter Grothusen, Bang-Jin Kim, Diqiu Ren, Zhendong Cao, Qinglan Li, Yiman Liu, Arati A Inamdar, Thomas Beer, Hsin-Yao Tang, Eric Perkey, Ivan P Maillard, Roberto Bonasio, Junwei Shi, Marco Ruella, Liling Wan, Luca Busino
DLBCL associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemo-resistance. Blood (2023)
Daniele Simoneschi, Gergely Rona, Nan Zhou, Yeon-Tae Jeong, Shaowen Jiang, Giacomo Milletti, Arnaldo A Arbini, Alfie O'Sullivan, Andrew A Wang, Sorasicha Nithikasem, Sarah Keegan, Yik Siu, Valentina Cianfanelli, Emiliano Maiani, Francesca Nazio, Francesco Cecconi, Francesco Boccalatte, David Fenyö, Drew R Jones, Luca Busino, Michele Pagano
CRL4AMBRA1 is a master regulator of D-type cyclins. Nature 592 (7856) (2021)
Rizwan Saffie, Nan Zhou, Delphine Rolland, Özlem Önder, Venkatesha Basrur, Sydney Campbell, Kathryn E Wellen, Kojo S J Elenitoba-Johnson, Brian C Capell, Luca Busino
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells. Cancer research 80 (12) (2020)